Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
NEXTGEN HEALTHCARE, INC. (NXGN)
|
Add to portfolio |
|
|
|
| Price: |
$18.09
| | Metrics |
| OS: |
68.0
|
M
| |
|
|
| Market cap: |
$1.23
|
B
| |
|
|
|
Net cash:
|
$238
|
M
| |
$3.50
|
per share
|
|
EV:
|
$992
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$69.4
|
M
| |
14.3
|
x EV/EBITDA
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Mar-05-23 | Mar-31-22 | Mar-05-22 | Mar-31-21 | Mar-31-20 | Mar-31-19 | Mar-31-18 | Mar-31-17 |
| Revenues | 653.2 | 596.4 | 596.4 | 556.8 | 540.2 | 529.2 | 531.0 | 509.6 |
| Revenue growth | 9.5% | 7.1% | | 3.1% | 2.1% | -0.3% | 4.2% | 3.5% |
| Cost of goods sold | 342.0 | 298.9 | 295.4 | 279.9 | 271.6 | 251.0 | 249.3 | 233.6 |
| Gross profit | 311.2 | 297.4 | 300.9 | 276.9 | 268.7 | 278.1 | 281.7 | 276.1 |
| Gross margin | 47.6% | 49.9% | 50.5% | 49.7% | 49.7% | 52.6% | 53.0% | 54.2% |
| Selling, general and administrative | 223.4 | 209.7 | 209.7 | 180.5 | 165.2 | 164.9 | 193.2 | 163.6 |
| Research and development | 82.3 | 76.7 | 76.7 | 75.5 | 83.3 | 81.0 | 81.3 | 78.3 |
| EBITA | 5.4 | 23.5 | 14.6 | 42.0 | 42.7 | 53.8 | 30.6 | 56.6 |
| EBITA margin | 0.8% | 3.9% | 2.5% | 7.5% | 7.9% | 10.2% | 5.8% | 11.1% |
| Amortization of intangibles | 3.7 | 12.4 | 3.5 | 21.1 | 22.5 | 21.5 | 23.4 | 22.5 |
| EBIT | 1.8 | 11.1 | 11.1 | 20.9 | 20.2 | 32.3 | 7.2 | 34.1 |
| EBIT margin | 0.3% | 1.9% | 1.9% | 3.8% | 3.7% | 6.1% | 1.4% | 6.7% |
| Pre-tax income | 4.3 | 5.2 | 5.2 | 9.3 | 4.3 | 29.3 | -0.4 | 23.6 |
| Income taxes | 7.0 | 3.6 | 3.6 | -0.2 | -3.2 | 4.8 | -2.8 | 5.4 |
| Tax rate | 161.7% | 68.9% | 68.9% | | | 16.4% | 690.2% | 22.7% |
| Net income | -2.7 | 1.6 | 1.6 | 9.5 | 7.5 | 24.5 | 2.4 | 18.2 |
| Net margin | -0.4% | 0.3% | 0.3% | 1.7% | 1.4% | 4.6% | 0.5% | 3.6% |
| |
| Diluted EPS | ($0.04) | $0.02 | $0.02 | $0.14 | $0.11 | $0.38 | $0.04 | $0.29 |
| Shares outstanding (diluted) | 67.0 | 67.8 | 67.8 | 66.9 | 65.6 | 64.6 | 63.4 | 62.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|